# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Hemangioendothelioma

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 11 results.
Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)
Status: Recruiting
Last Changed: Nov 15, 2019
First Received: Nov 06, 2017
Disease(s): Angiosarcoma, Epithelioid Hemangioendothelioma
Intervention(s): Eribulin
Locations: Massachusetts General Hospital, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Sirolimus Plus Propranolol Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma
Status: Recruiting
Last Changed: Jul 23, 2019
First Received: Jun 15, 2017
Disease(s): Kaposiform Hemangioendothelioma, Kasabach Merritt Phenomenon
Intervention(s): Sirolimus, Prednisolone, Propranolol
Locations: West China Hospital of Sichuan University, Chengdu, Sichuan, China
Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery
Status: Recruiting
Last Changed: Jan 21, 2020
First Received: May 10, 2017
Disease(s): Epithelioid Hemangioendothelioma, Locally Advanced Epithelioid Hemangioendothelioma, Metastatic Epithelioid Hemangioendothelioma
Intervention(s): Questionnaire Administration, Trametinib
Locations: Mayo Clinic Hospital, Phoenix, Arizona, United States
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Stanford Cancer Institute Palo Alto, Palo Alto, California, United States
University of Colorado Hospital, Aurora, Colorado, United States
Smilow Cancer Center/Yale-New Haven Hospital, New Haven, Connecticut, United States
... and 32 other locations.
Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma
Status: Recruiting
Last Changed: Oct 03, 2019
First Received: Aug 14, 2019
Disease(s): Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma
Intervention(s): Tacrolimus ointment
Locations: West China Hospital of Sichuan University, Chengdu, Sichuan, China
Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
Status: Recruiting
Last Changed: Sep 04, 2019
First Received: Sep 04, 2019
Disease(s): Hemangioma, Kaposiform Hemangioendothelioma
Intervention(s): Sirolimus(0.8mg/m2), Sirolimus(0.7mg/m2)
Locations: Children's Hospital of Fudan University, Shanghai, China
Diagnostic Accuracy of PIVKA-II Combining With Alpha-Fetoprotein in Hepatic Tumor
Status: Recruiting
Last Changed: Jul 12, 2019
First Received: Aug 24, 2018
Disease(s): Hepatoblastoma, Hepatic Hemangioendothelioma
Intervention(s): PIVKA-II
Locations: Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization.
Status: Recruiting
Last Changed: Feb 19, 2020
First Received: Dec 09, 2015
Disease(s): Congenital Hemangioma, Hemangioendothelioma, Angiosarcoma, Arteriovenous Malformation
Intervention(s): Lipiodol® Ultra Fluid with surgical glues
Locations: Division of Peripheral Vascular & Endovascular sciences, Medanta-The Medicity Hospital, Gurgaon, Haryana, India
Christian Medical College Hospital, Vellore, Tamil Nadu, India
Identification of Biomarkers for Patients With Vascular Anomalies
Status: Recruiting
Last Changed: Feb 05, 2020
First Received: Dec 22, 2016
Disease(s): Vascular Anomaly, Generalized Lymphatic Anomaly, Kaposiform Hemangioendothelioma, Kaposiform Lymphangiomatosis, Gorham-Stout Disease, Klippel Trenaunay Syndrome, Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi
Locations: Boston Children's Hospital, Boston, Massachusetts, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Status: Not yet recruiting
Last Changed: May 30, 2019
First Received: May 30, 2019
Disease(s): Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma, Perivascular Epithelioid Cell Neoplasms, Desmoplastic Small Round Cell Tumor, Solitary Fibrous Tumors, Alveolar Soft Part Sarcoma, Epithelioid Hemangioendothelioma, Low Grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma
Intervention(s): Patient with Soft Tissue Sarcoma
Locations: Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients
Status: Not yet recruiting
Last Changed: Jan 09, 2020
First Received: Jul 05, 2019
Disease(s): Soft Tissue Sarcoma Adult, Undifferentiated Pleomorphic Sarcoma, Epithelioid Sarcoma, Solitary Fibrous Tumors, Hemangioendothelioma, Desmoplastic Round Cell Tumor, Synovial Sarcoma
Intervention(s): Trabectedin
Locations: Institut Bergonie, Bordeaux, France